Abstract
We evaluated the i-peptides occurrence frequency in the protein sequences, belonging to two reference datasets containing structured and disordered protein domains. Moreover we estimated the most frequent i-peptides (with i= 2, 3, 4) into these sequences in order to select specific i-peptides for each structural classification. According to these specific ipeptides, a new binary classification method was developed for predicting if a given protein sequence can be classified as “disordered” or “structured”. The best results were obtained using the tri-peptides, much more able to gain structural information from sequences compared to the di-peptides.
Keywords: Binary classification method, disordered proteins, disorder prediction, peptides occurrence frequency, protein folding, protein unfolding, method, disordered, disorder, peptides, protein, unfolding, i-peptides, DNA, AD, (NACP), p53, (IUPs), 25PDB, DisProt, specific i-peptides, validation, correlation coefficient, weighted score, CASP8, PREDISPRO, CGI, hydrophilic, 3-Dstructure, (AC), PREC-LASSPRO, CH-plot
Protein & Peptide Letters
Title: Frequencies of Specific Peptides in Intrinsic Disordered Protein Domains
Volume: 17 Issue: 11
Author(s): Susan Costantini, Maria Costantini and Giovanni Colonna
Affiliation:
Keywords: Binary classification method, disordered proteins, disorder prediction, peptides occurrence frequency, protein folding, protein unfolding, method, disordered, disorder, peptides, protein, unfolding, i-peptides, DNA, AD, (NACP), p53, (IUPs), 25PDB, DisProt, specific i-peptides, validation, correlation coefficient, weighted score, CASP8, PREDISPRO, CGI, hydrophilic, 3-Dstructure, (AC), PREC-LASSPRO, CH-plot
Abstract: We evaluated the i-peptides occurrence frequency in the protein sequences, belonging to two reference datasets containing structured and disordered protein domains. Moreover we estimated the most frequent i-peptides (with i= 2, 3, 4) into these sequences in order to select specific i-peptides for each structural classification. According to these specific ipeptides, a new binary classification method was developed for predicting if a given protein sequence can be classified as “disordered” or “structured”. The best results were obtained using the tri-peptides, much more able to gain structural information from sequences compared to the di-peptides.
Export Options
About this article
Cite this article as:
Costantini Susan, Costantini Maria and Colonna Giovanni, Frequencies of Specific Peptides in Intrinsic Disordered Protein Domains, Protein & Peptide Letters 2010; 17 (11) . https://dx.doi.org/10.2174/0929866511009011398
DOI https://dx.doi.org/10.2174/0929866511009011398 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pulmonary Arterial Hypertension in Connective Tissue Diseases
Current Respiratory Medicine Reviews Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation
Current Neuropharmacology The Role of Metabolism in Toxicity of Polycyclic Aromatic Hydrocarbons and their Non-genotoxic Modes of Action
Current Drug Metabolism Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
Current Pharmaceutical Design The Role of Advanced Technologies Supplemented with Traditional Methods in Pharmacovigilance Sciences
Recent Patents on Biotechnology Pharmacotherapy of Obesity - Benefit, Bias and Hyperbole
Current Medicinal Chemistry Nephroangiosclerosis and Its Pharmacological Approach
Current Vascular Pharmacology Role of Endothelin in Uteroplacental Circulation and Fetal Vascular Function
Current Vascular Pharmacology Molecular Markers of Cardiovascular Damage in Hypertension
Current Pharmaceutical Design Renal Ischemia: How Commonly Does it Cause Renal Failure?
Current Hypertension Reviews Application of Dual-Source CT Coronary Angiography in Type 2 Diabetic Patients with Symptomatic Coronary Heart Disease
Current Vascular Pharmacology Clinical Evaluation of Anti-Obesity Drugs
Current Drug Targets Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Current Diabetes Reviews Mesenchymal Stromal Cells from Umbilical Cord Blood
Current Stem Cell Research & Therapy Gene Therapy in Cardiovascular Diseases
Current Gene Therapy Cardioprotective Role of <i>Theobroma cacao</i> against Isoproterenol-Induced Acute Myocardial Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry COX-2 Inhibitors and Cardiovascular Events: Deja Vu Du Jour
Vascular Disease Prevention (Discontinued) In Silico Classification and Prediction of VIP Derivatives as VPAC1/ VPAC2 Receptor Agonists/Antagonists
Combinatorial Chemistry & High Throughput Screening Adeno-associated Viral Vectors for Correction of Inborn Errors of Metabolism: Progressing Towards Clinical Application
Current Pharmaceutical Design Current Treatment Concepts of Philadelphia-Negative MPN
Current Cancer Drug Targets